IP Library Granted Patent US 7,696,404
Granted Patent B2
US 7,696,404 · App. 10/329,979 · Granted Apr 13, 2010

Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions

Assignee: Advanced Cell Technology, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,696,404
App. No.
10/329,979
Granted
Apr 13, 2010
Kind
B2
Abstract

An improved method of nuclear transfer involving the transplantation of differentiated donor cell nuclei into enucleated oocytes of a species different from the donor cell is provided. The resultant nuclear transfer units are useful for the production of isogenic embryonic stem cells, in particular human isogenic embryonic or stem cells. These embryonic or stem-like cells are useful for producing desired differentiated cells and for introduction, removal or modification, of desired genes, e.g., at specific sites of the genome of such cells by homologous recombination. These cells, which may contain a heterologous gene, are especially useful in cell transplantation therapies and for in vitro study of cell differentiation. Also, methods for improving nuclear transfer efficiency by genetically altering donor cells to inhibit apoptosis, select for a specific cell cycle and/or enhance embryonic growth and development are provided.

Claims (7)

1. A method for producing a nuclear transfer human/rabbit blastocyst by cross-species nuclear transfer to give rise to embryonic stem-like cells comprising:

(i) inserting a human cell or human cell nucleus into an enucleated recipient rabbit oocyte under conditions suitable for the formation of a nuclear transfer (NT) unit;

(ii) activating the NT unit formed in step (i); and

(iii) culturing the NT unit until the blastocyst stage to give rise to embryonic stem-like cells, wherein the embryonic stem-like cells are pluripotent.

2. The method of claim 1 which further comprises transferring the nucleus of the NT unit from step (i) into another rabbit oocyte which is enucleated before transfer of the nucleus.

3. The method of claim 1 wherein the nuclear transfer blastocyst produced by step (iii) is cultured on a feeder layer.

4. The method of claim 3 wherein the blastocyst is cultured on a fibroblast feeder layer.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 24, 2014
From: CAMOFI MASTER LDC; CAMHZN MASTER LDC
To: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
Reel/Frame 034421/0863 →
SECURITY AGREEMENT Recorded Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2003
From: CIBELLI, JOSE; WEST, MICHAEL D.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 014213/0565 →
Continuity (16)
Continuation In Part 0946707600 · Dec 20, 1999
Continuation In Part 0939536800 · Sep 14, 1999
Continuation In Part 0926046800 · Mar 2, 1999
Continuation In Part 0903294500 · Mar 2, 1998
Continuation In Part 0869904000 · Aug 19, 1996
Continuation In Part 0968506100 · Oct 6, 2000
Continuation In Part 0926046800 · Mar 2, 1999
Continuation In Part 1032997900
Continuation In Part 0987404000 · Jun 6, 2001
Continuation In Part 0869904000 · Aug 19, 1996
Continuation In Part 1032997900
Continuation In Part 0980901800 · Mar 16, 2001
Continuation In Part 0903294500 · Mar 2, 1998
Provisional Application 6034235800 · Dec 27, 2001
Provisional Application 6035784800 · Feb 21, 2002
Related Publication 20030229908A1 · Dec 11, 2003